LOGO
LOGO

TODAY'S TOP STORIES

Aetna To Buy Coventry Health Care For $5.7 Bln In Cash And Stock: WSJ

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024

Aetna Inc. (AET) has agreed to buy Coventry Health Care Inc. (CVH) for $5.7 billion in cash and stock, making itself a prominent player in the government-financed health care, the Wall Street Journal reported, quoting people familiar with the matter.

Aetna will pay $42.08 per share for Coventry. This is a premium of 20.4 percent to Coventry's closing price on Friday.

While 65 percent of the value will be paid in cash, 35 percent will be in the form of stock. The $42.08 per share offer is a combination of cash and 0.3885 share of Aetna for each Coventry share. Including assumption debt, the deal is valued at $7.3 billion.

The boards of both companies have approved the deal. The deal is expected to be announced on Monday, the report said.

The deal could help the company expand in the government-based health plans, which includes Medicare for the elderly and Medicaid for the poor. Under Obama's healthcare reform law, Medicaid is set to expand from 2014.

It is expected that the deal will increase Aetna's share of revenue from the government-based business to 30 percent from the current 23 percent. The acquisition is also expected to add to Aetna's earnings by around 45 cents per share in 2014 and 90 cents per share in 2015, according to the report.

AET settled lower by 0.3 percent on Friday at $38.04.

CVH gained 0.7 percent to close at $34.94.

For comments and feedback contact: editorial@rttnews.com

Business News

Global Economics Weekly Update - Jun 01 - Jun 05, 2026

June 05, 2026 16:18 ET
A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.

Latest Updates on COVID-19